Cargando…
Multiple Biologics for Multiple T2 Diseases: A Pharmacoepidemiological Algorithm for Sorting Out Patients by Indication
BACKGROUND: Several biologics (Bx) and targeted synthetic drugs (TSD) exist to treat T2 diseases, including chronic spontaneous urticaria (CSU), severe asthma (SA), chronic rhinosinusitis with nasal polyposis (CRSwNP) or atopic dermatitis (AD). OBJECTIVE: To identify patients treated with Bx/TSD fro...
Autores principales: | Charriot, Jeremy, Descamps, Vincent, Jankowski, Roger, Maravic, Milka, Bourdin, Arnaud |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10693777/ https://www.ncbi.nlm.nih.gov/pubmed/38050615 http://dx.doi.org/10.2147/JAA.S424152 |
Ejemplares similares
-
“Real-life” management of patients with severe asthma in the biologics era: Can we do better?()
por: Charriot, Jeremy, et al.
Publicado: (2021) -
Impact of COVID-19 on initiation of biologic therapy prescriptions for chronic inflammatory diseases
por: Richette, Pascal, et al.
Publicado: (2022) -
Methods of Sputum and Mucus Assessment for Muco-Obstructive Lung Diseases in 2022: Time to “Unplug” from Our Daily Routine!
por: Charriot, Jeremy, et al.
Publicado: (2022) -
Artificial intelligence to differentiate asthma from COPD in medico-administrative databases
por: Joumaa, Hassan, et al.
Publicado: (2022) -
Pharmacovigilance and Pharmacoepidemiology
Publicado: (2008)